NeoPharm CO. LTD (092730) — Free Cash Flow Generation Index
NeoPharm CO. LTD (092730) has a Free Cash Flow Generation Index of 0.92x as of September 2025. Free cash flow of ₩5.43 Billion represents 1% of operating cash flow (₩5.88 Billion). Read 092730 liabilities breakdown for a breakdown of total debt and financial obligations.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
NeoPharm CO. LTD Free Cash Flow Generation Index (2012–2024)
Historical FCF Generation Index trend for NeoPharm CO. LTD across 11 annual periods. Explore 092730 capex to operating cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Annual Free Cash Flow Generation for NeoPharm CO. LTD (2012–2024)
Year-by-year Free Cash Flow Generation Index for NeoPharm CO. LTD. For the full company profile including market capitalisation, see how much is NeoPharm CO. LTD worth.
| Year | FCG Index | Free Cash Flow (KRW) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.83x | ₩15.55 Billion | ₩18.63 Billion | ₩3.08 Billion | ▲ +697.6% |
| 2023 | 0.10x | ₩2.43 Billion | ₩23.26 Billion | ₩20.83 Billion | ▼ -89.0% |
| 2022 | 0.96x | ₩17.35 Billion | ₩18.16 Billion | ₩806.43 Million | ▼ -2.3% |
| 2021 | 0.98x | ₩21.20 Billion | ₩21.68 Billion | ₩320.11 Million | ▲ +2.2% |
| 2020 | 0.96x | ₩16.34 Billion | ₩17.07 Billion | ₩285.62 Million | ▼ -17.5% |
| 2019 | 1.16x | ₩22.31 Billion | ₩19.22 Billion | ₩5.90 Billion | ▲ +3.6% |
| 2018 | 1.12x | ₩18.12 Billion | ₩16.18 Billion | ₩1.94 Billion | ▲ +3.4% |
| 2017 | 1.08x | ₩11.53 Billion | ₩10.65 Billion | ₩884.71 Million | ▼ -6.1% |
| 2016 | 1.15x | ₩10.56 Billion | ₩9.16 Billion | ₩1.40 Billion | ▲ +2.2% |
| 2015 | 1.13x | ₩6.88 Billion | ₩6.09 Billion | ₩786.89 Million | ▼ -13.5% |
| 2012 | 1.31x | ₩736.81 Million | ₩564.34 Million | ₩172.47 Million | — |